XML 25 R12.htm IDEA: XBRL DOCUMENT
v3.20.2

GOODWILL AND OTHER INTANGIBLE ASSETS | 6 Months Ended
--- | ---
Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND OTHER INTANGIBLE ASSETS | GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Changes in the carrying amount of goodwill for the six-month period ended June 30, 2020 were as follows:
| Codman Specialty Surgical |  | Orthopedics and Tissue Technologies |  | Total
| (In thousands)
Goodwill at December 31, 2019 | $ | 653,500 |  |  | $ | 300,780 |  |  | $ | 954,280 |
Foreign currency translation | 1,320 |  |  | 607 |  |  | 1,927 |
Goodwill at June 30, 2020 | $ | 654,820 |  |  | $ | 301,387 |  |  | $ | 956,207 |
The components of the Company’s identifiable intangible assets were as follows:
| June 30, 2020
| Weighted Average Life |  | Cost |  | Accumulated Amortization |  | Net
| (Dollars in thousands)
Completed technology | 19 years |  | $ | 885,015 |  |  | $ | (237,580 | ) |  | $ | 647,435 |
Customer relationships | 12 years |  | 222,249 |  |  | (131,273 | ) |  | 90,976 |
Trademarks/brand names | 28 years |  | 103,794 |  |  | (30,277 | ) |  | 73,517 |
Codman tradename | Indefinite |  | 164,787 |  |  | — |  |  | 164,787 |
Supplier relationships | 27 years |  | 34,721 |  |  | (18,661 | ) |  | 16,060 |
All other(1) | 4 years |  | 10,879 |  |  | (4,968 | ) |  | 5,911 |
|  |  | $ | 1,421,445 |  |  | $ | (422,759 | ) |  | $ | 998,686 |
| December 31, 2019
| Weighted Average Life |  | Cost |  | Accumulated Amortization |  | Net
| (Dollars in thousands)
Completed technology | 19 years |  | $ | 880,623 |  |  | $ | (213,702 | ) |  | $ | 666,921 |
Customer relationships | 12 years |  | 222,575 |  |  | (119,393 | ) |  | 103,182 |
Trademarks/brand names | 28 years |  | 103,873 |  |  | (28,514 | ) |  | 75,359 |
Codman tradename | Indefinite |  | 163,126 |  |  | — |  |  | 163,126 |
Supplier relationships | 27 years |  | 34,721 |  |  | (17,947 | ) |  | 16,774 |
All other (1) | 4 years |  | 10,869 |  |  | (4,640 | ) |  | 6,229 |
|  |  | $ | 1,415,787 |  |  | $ | (384,196 | ) |  | $ | 1,031,591 |
(1) | At June 30, 2020 and December 31, 2019, all other included IPR&D of $1.0 million, which was indefinite-lived.
Based on quarter-end exchange rates, amortization expense (including amounts reported in cost of product revenues) is expected to be approximately $36.4 million for the remainder of 2020, $64.5 million in 2021, $61.0 million in 2022, $60.1 million in 2023, $59.2 million in 2024, $59.2 million in 2025 and $492.7 million thereafter.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration